22 results on '"Chen, Zhe-Sheng"'
Search Results
2. Therapeutic implication of carbon monoxide in drug resistant cancers
3. CMP25, a synthetic new agent, targets multidrug resistance-associated protein 7 (MRP7/ABCC10)
4. Cellular mechanisms of the cytotoxicity of the anticancer drug elesclomol and its complex with Cu(II)
5. CEP-33779 antagonizes ATP-binding cassette subfamily B member 1 mediated multidrug resistance by inhibiting its transport function
6. Motesanib (AMG706), a potent multikinase inhibitor, antagonizes multidrug resistance by inhibiting the efflux activity of the ABCB1
7. Telatinib reverses chemotherapeutic multidrug resistance mediated by ABCG2 efflux transporter in vitro and in vivo
8. Parguerenes: Marine red alga bromoditerpenes as inhibitors of P-glycoprotein (ABCB1) in multidrug resistant human cancer cells
9. The Pim kinase inhibitor SGI-1776 decreases cell surface expression of P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) and drug transport by Pim-1-dependent and -independent mechanisms
10. OSI-930 analogues as novel reversal agents for ABCG2-mediated multidrug resistance
11. GW583340 and GW2974, human EGFR and HER-2 inhibitors, reverse ABCG2- and ABCB1-mediated drug resistance
12. Biological evaluation of non-basic chalcone CYB-2 as a dual ABCG2/ABCB1 inhibitor
13. Marine sponge-derived sipholane triterpenoids reverse P-glycoprotein (ABCB1)-mediated multidrug resistance in cancer cells
14. Lapatinib and erlotinib are potent reversal agents for MRP7 (ABCC10)-mediated multidrug resistance
15. Sensitization of ABCB1 overexpressing cells to chemotherapeutic agents by FG020326 via binding to ABCB1 and inhibiting its function
16. Nilotinib (AMN107, Tasigna®) reverses multidrug resistance by inhibiting the activity of the ABCB1/Pgp and ABCG2/BCRP/MXR transporters
17. Inhibiting the function of ABCB1 and ABCG2 by the EGFR tyrosine kinase inhibitor AG1478
18. Cepharanthine is a potent reversal agent for MRP7(ABCC10)-mediated multidrug resistance
19. Tepotinib reverses ABCB1-mediated multidrug resistance in cancer cells
20. Ulixertinib (BVD-523) antagonizes ABCB1- and ABCG2-mediated chemotherapeutic drug resistance
21. Selective reversal of BCRP-mediated MDR by VEGFR-2 inhibitor ZM323881
22. Nilotinib (AMN107, Tasigna®) reverses multidrug resistance by inhibiting the activity of the ABCB1/Pgp and ABCG2/BCRP/MXR transporters
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.